Objectives: To estimate the number of patients who started methylphenidate during
childhood and continued treatment beyond the age of 18 years and to study the …

Objectives: Numerous studies have examined determinants contributing to methylphenidate
adherence and persistence, but these were mainly conducted in adults. These determinants …

Objectives: To determine methylphenidate use in children aged 2 to 13 years. To provide
age-and sex-specific estimates of methylphenidate initiation and cessation during a 2-year …

Methylphenidate (MPH) is a common and effective treatment for attention deficit hyperactivity
disorder (ADHD), but little is known about the relationship between early childhood intake of …

Objective: To provide age-and sex-specific estimates of methylphenidate use and to
determine use changes over a 2-year period. Study design: We examined the first and …

OBJECTIVES: To identify methylphenidate profiles over several years in a national sample
of boys and examine behavioral and sociodemographic predictors of use. STUDY DESIGN …

Objective: Previous population-based studies have identified factors accounting for
differential utilization of psychotropic medications among young patients with attention …

Previous studies have suggested that risk of psychotic events may be increased in children
exposed to methylphenidate (MPH). However, this risk has not been fully examined, and the …

Background Our review of the scientific literature focused on an analysis of studies
describing instances of methylphenidate treatment leading (or not) to behavioral changes in …

Objective Methylphenidate (MPH) is a prescription-stimulant medication which is authorized
in France for two indications: attention-deficit hyperactivity disorder in children (aged≥ 6 …